Letter: Recognition of diphtheria

The 50th anniversary of the discovery of 6-aminopenicillanic acid (6-APA).

International journal of antimicrobial agents·2006

Grepafloxacin: an overview of antibacterial activity, pharmacokinetics, clinical efficacy and safety.

Expert opinion on investigational drugs·2005

Randomized comparative trial of cefpirome versus ceftazidime in the empirical treatment of suspected bacteraemia or sepsis. Multicentre Study Group.

The Journal of antimicrobial chemotherapy·1998

Empiric therapy in lower respiratory tract infection--an ongoing challenge.

Journal of chemotherapy (Florence, Italy)·1997

Tempting fate: control of communicable disease in England.

BMJ (Clinical research ed.)·1993

Safety of fleroxacin in clinical trials.

The American journal of medicine·1993

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Clinical and neuropsychological profile of Alzheimer's disease in Tunisia and the impact of <i>APOE</i> gene.

Frontiers in genetics·2026

Low-dose Aspirin Once Daily is Noninferior for Venous Thromboembolic Prophylaxis After Primary Total Joint Arthroplasty: An Analysis of 8,073 Cases Over 10 Years.

The Journal of arthroplasty·2026

Risk of Inguinal Hernia Repair Following Laparoscopic Living Donor Nephrectomy: A Population-Based Cohort Study.

Canadian journal of kidney health and disease·2026

Hospital Safety Index in Thailand: Emergency Staff Perspectives on Preparedness and Trust.

Nursing open·2026

Etomidate Is Associated with Higher 30-Day Mortality than Ketamine for Emergency Intubation of COVID-19 Patients: A Propensity-Matched Cohort Study.

Journal of clinical medicine·2026

Septic Shock, Infective Endocarditis, Septic Embolization and Disseminated Intravascular Coagulation Caused by a Toxigenic <i>C. diphtheriae</i> Strain: A Case Report.

Healthcare (Basel, Switzerland)·2026

Related Experiment Videos

Letter: Recognition of diphtheria

Related Concept Videos

The 50th anniversary of the discovery of 6-aminopenicillanic acid (6-APA).

Grepafloxacin: an overview of antibacterial activity, pharmacokinetics, clinical efficacy and safety.

Randomized comparative trial of cefpirome versus ceftazidime in the empirical treatment of suspected bacteraemia or sepsis. Multicentre Study Group.

Empiric therapy in lower respiratory tract infection--an ongoing challenge.

Tempting fate: control of communicable disease in England.

Safety of fleroxacin in clinical trials.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Clinical and neuropsychological profile of Alzheimer's disease in Tunisia and the impact of <i>APOE</i> gene.

Low-dose Aspirin Once Daily is Noninferior for Venous Thromboembolic Prophylaxis After Primary Total Joint Arthroplasty: An Analysis of 8,073 Cases Over 10 Years.

Risk of Inguinal Hernia Repair Following Laparoscopic Living Donor Nephrectomy: A Population-Based Cohort Study.

Hospital Safety Index in Thailand: Emergency Staff Perspectives on Preparedness and Trust.

Etomidate Is Associated with Higher 30-Day Mortality than Ketamine for Emergency Intubation of COVID-19 Patients: A Propensity-Matched Cohort Study.

Septic Shock, Infective Endocarditis, Septic Embolization and Disseminated Intravascular Coagulation Caused by a Toxigenic <i>C. diphtheriae</i> Strain: A Case Report.

Related Experiment Videos

Letter: Recognition of diphtheria

Related Concept Videos

Related Articles